Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-12-000875
Filing Date
2012-02-14
Accepted
2012-02-14 15:48:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 c68546_13g.htm SC 13G/A 65412
  Complete submission text file 0000930413-12-000875.txt   67055
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Subject) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44057 | Film No.: 12609163
SIC: 2834 Pharmaceutical Preparations

Mailing Address 730 THIRD AVENUE NEW YORK NY 10017-3206
Business Address 730 THIRD AVENUE NEW YORK NY 10017-3206 2129166042
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by) CIK: 0000887793 (see all company filings)

EIN.: 133586142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A